Overview

A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to select an optimum dose may be selected based on bronchodilator efficacy, safety evaluations and pharmacokinetics of tiotropium bromide.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Collaborator:
Pfizer
Treatments:
Bromides
Pharmaceutical Solutions
Tiotropium Bromide